Can an adult be diagnosed with Intermittent Explosive Disorder (IED) without a comprehensive clinical interview?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Diagnose an Adult with Intermittent Explosive Disorder?

Yes, you can diagnose an adult with IED, but a comprehensive structured or semi-structured clinical interview is essential and should not be bypassed. The diagnosis requires careful assessment to exclude other conditions and confirm the specific pattern of impulsive aggression 1.

Diagnostic Requirements

Essential Clinical Interview Components

A structured diagnostic interview (such as SCID-I) is necessary to ensure accurate diagnosis 1, 2. This is not optional—attempting to diagnose IED without this thorough assessment risks misdiagnosis and inappropriate treatment that could worsen outcomes.

The interview must establish:

  • Discrete episodes of aggressive impulses resulting in serious assaults or property destruction
  • Tension or arousal immediately preceding the aggressive acts (reported by 88% of patients) 2
  • Relief or even pleasure after performing the act (75% experience relief, 48% experience pleasure) 2
  • Disproportionate response to the precipitating stressor
  • Mean age at onset around 14-16 years, though diagnosis often occurs much later 3, 4

Critical Differential Diagnosis Work-Up

Before confirming IED, you must systematically rule out:

Psychiatric comorbidities (present in 95.7% of IED cases):

  • Mood disorders (93% lifetime prevalence) 2, 5
  • Substance use disorders (48%) 2
  • Anxiety disorders (48%) 2
  • Other impulse-control disorders (44%) 2
  • Personality disorders, particularly Cluster B 5

Medical conditions:

  • Neurological disorders: epilepsy (HR 4.9), neurodegenerative diseases (HR 5.0), movement disorders (HR 3.1) 5
  • Traumatic brain injury history 6
  • Sleep disorders (HR 2.2) 5

Substance intoxication or withdrawal must be excluded at the time of assessment 7

Common Diagnostic Pitfalls

The Comorbidity Trap

Do not dismiss IED diagnosis simply because other psychiatric conditions are present. The extensive comorbidity (95.7% have another psychiatric diagnosis) means that waiting for a "pure" presentation will result in underdiagnosis 5. Instead, determine if the aggressive episodes represent a distinct pattern beyond what the comorbid condition explains.

The Personality Disorder Exclusion Debate

While older criteria excluded IED in the presence of antisocial or borderline personality disorders, current practice recognizes that diagnosing both conditions allows identification of a treatable subgroup 6. The recurrent violent behavior is not universal in these personality disorders, and the IED diagnosis permits targeted anger treatment.

The Underdiagnosis Problem

Despite lifetime prevalence of 5-7% in community samples 3, 8, only 0.03% receive the diagnosis in clinical settings 5. Only 28.8% of individuals with IED ever receive treatment for their anger 3, representing a massive treatment gap. Be alert for this diagnosis in patients presenting with other psychiatric complaints.

Assessment Algorithm

  1. Conduct structured diagnostic interview (SCID-I or equivalent) to establish DSM-5 criteria 1, 4

  2. Assess for characteristic phenomenology:

    • Pre-assault tension (present in 88%)
    • Post-assault relief (75%) or pleasure (48%)
    • Associated affective symptoms (mood/energy changes) 2
  3. Complete medical work-up to exclude neurological causes 1, 6

  4. Evaluate cognitive function if substance use is present—base assessment on cognitive abilities rather than arbitrary blood alcohol levels 7

  5. Document pattern: Average of 43 lifetime attacks, mean property damage $1,359, and 180 injuries per 100 lifetime cases 3

  6. Screen for extensive comorbidities using validated instruments (SCL-90, aggression scales, impulsivity measures) 4

Clinical Context

IED causes severe functional impairment and represents a significant public health concern given its early onset (adolescence), high comorbidity burden, and low treatment rates 3, 5. The diagnosis is valid across cultures, with global prevalence around 5.1% lifetime 8, though rates are higher in clinical populations (10.5%), refugees (8.5%), and males (OR 3.39) 8.

The structured interview requirement reflects the complexity of distinguishing IED from other conditions with aggressive features and ensures appropriate treatment targeting the specific neurocognitive deficits in cognitive inhibition, behavioral inhibition, and emotional interference that characterize this disorder 9.

Related Questions

What medication should be used to treat an adult with intermittent explosive disorder who has no contraindicating medical conditions?
Can I assign a diagnosis and ICD‑10‑CM code for Intermittent Explosive Disorder (F63.81) in a 34‑year‑old male when the only information comes from staff observations?
What are the DSM‑5‑TR diagnostic criteria for Intermittent Explosive Disorder (IED)?
How should I document the impulsive aggressive outbursts of a 34‑year‑old male (including frequency, duration, lack of premeditation, and absence of mood, substance‑use, or neurological disorder) to accurately code Intermittent Explosive Disorder (F63.81)?
What is the ICD‑10‑CM code for Intermittent Explosive Disorder (IED)?
What are the possible causes and recommended work‑up for an elevated C‑reactive protein with a normal erythrocyte sedimentation rate and normal complete blood count?
In a patient with well‑controlled type 2 diabetes (A1C 5.5%) on dapagliflozin (Jardiance) who also has heart failure, should dapagliflozin be continued?
In a diabetic patient with peripheral arterial disease who now has foot erythema and tenderness, what is the appropriate initial evaluation and management?
Which generic anastrozole formulation has inactive ingredients that differ from the brand Arimidex (anastrozole)?
Is it safe to use hydroxyzine as needed for anxiety in a patient taking dronedarone (Multaq), metoprolol, hydrochlorothiazide, and apixaban (Eliquis)?
For a 70-year-old female diagnosed with schizophrenia who is experiencing an acute psychotic episode and has a past medical history of hypertension, diabetes mellitus, and peripheral arterial disease, what medication and dose are recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.